Viewing Study NCT00031993


Ignite Creation Date: 2025-12-25 @ 1:04 AM
Ignite Modification Date: 2026-03-01 @ 8:33 PM
Study NCT ID: NCT00031993
Status: COMPLETED
Last Update Posted: 2013-01-17
First Post: 2002-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cervical Squamous Cell Carcinoma View
None Recurrent Cervical Cancer View
Keywords: